Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

2.99
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
2.69
Today|||52-Week Range
5.66
+3.82%
Year-to-Date
No recent news for Achillion Pharmaceuticals Inc.

Today’s Trading

Previous close2.99
Today’s open2.93
Day’s range2.84 - 2.99
Volume1,687,681
Average volume (3 months)2,249,205
Market cap$406.7M
Data as of 3:59pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)-1,025.00%
Earnings growth (this year)-37.33%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-77.31%
P/E ratioNM
Price/Sales37.63
Price/Book1.01

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...0.000.00%
SGYPSynergy Pharmaceutic...0.000.00%
INSYINSYS Therapeutics I...0.000.00%
MGNXMacroGenics Inc0.000.00%
Data as of 4:00pm ET, 01/19/2018

Financials

Next reporting dateMarch 8, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.0M
Annual profit (last year)-$61.7M
Net profit margin-411.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
Chief Operating Officer &
Executive Vice President
Joseph Truitt
Corporate headquarters
New Haven, Connecticut

Forecasts